recombinant expressed sweet-tasting protein brazzein and its mutants in Escherichia coli

Removing of the N-terminal methionine improves the sweetness of the recombinant expressed sweet-tasting protein brazzein and its mutants in Escherichia coli

 

The sweet-tasting protein brazzein is the smallest candy protein with excessive candy efficiency. Overexpression of this protein in a heterogenous host is a vital means for its manufacturing in meals trade. On this research, the gene of minor kind brazzein was cloned into the pET-SUMO vector with optimized codon utilization and expressed in E. coli BL21-CodonPlus (DE3)-RIL.

 

The recombinant protein in absence of the N-terminal methionine displayed a sweetness threshold about 1.5 μg/ml, which is the sweetest brazzein protein reported to date. The surprising candy efficiency of the protein was validated by a sequence of mutants (7Val → Arg, 9Glu → Lys and 9Glu → Asp), wherein E9K exhibited about 50% enhancement of sweetness than the wild sort. The superior sweetness of recombinant brazzein and its sweeter mutants counsel their potential purposes in meals and drinks.

 

PRACTICAL APPLICATIONS: The sweet-tasting proteins are pure, low-, or non-caloric and nutritive, exhibiting to be promising replacers of sugars and synthetic sweeteners, and can be utilized as candy components within the fields of meals, drugs, and biotechnology. Within the current research, we report that the recombinant brazzein protein expressed in E. coli reveals superior and improved sweetness than these beforehand reported.

 

Moreover, sweeter mutants had been obtained with the expression process. The superior sweetness of recombinant brazzein and its sweeter mutants counsel their potential purposes in meals, drinks, and different fields.

 

Genoimmun
Genoimmun
Key phrases: E. coli expression; N-terminus; mutant; sweet-tasting protein brazzein; sweetness

Yeast AHA1 Protein

SPR-314C 2x0.1 mg
EUR 564
Description: His tagged recombinant yeast AHA1 Protein expressed in E. coli for WB, SDS-PAGE, Functional Assay. The biological activity of this protein has not yet been tested.

AHA1 protein

30R-1091 100 ug
EUR 305
Description: Purified recombinant Human AHA1 protein

Human AHA1 Protein

SPR-300A 0.05 mg
EUR 261
Description: Untagged recombinant human AHA1 Protein expressed in E. coli for WB, SDS-PAGE, Functional Assay. The biological activity of this protein has not yet been tested.

Human AHA1 Protein

SPR-300B 0.1 mg
EUR 377
Description: Untagged recombinant human AHA1 Protein expressed in E. coli for WB, SDS-PAGE, Functional Assay. The biological activity of this protein has not yet been tested.

Human AHA1 Protein

SPR-300C 2x0.1 mg
EUR 564
Description: Untagged recombinant human AHA1 Protein expressed in E. coli for WB, SDS-PAGE, Functional Assay. The biological activity of this protein has not yet been tested.

Human AHA1 Protein

SPR-309A 0.05 mg
EUR 261
Description: His tagged recombinant human AHA1 Protein expressed in E. coli for WB, SDS-PAGE, Functional Assay. The biological activity of this protein has not yet been tested.

Human AHA1 Protein

SPR-309B 0.1 mg
EUR 377
Description: His tagged recombinant human AHA1 Protein expressed in E. coli for WB, SDS-PAGE, Functional Assay. The biological activity of this protein has not yet been tested.

Human AHA1 Protein

SPR-309C 2x0.1 mg
EUR 564
Description: His tagged recombinant human AHA1 Protein expressed in E. coli for WB, SDS-PAGE, Functional Assay. The biological activity of this protein has not yet been tested.

Mouse AHA1 Protein

SPR-311A 0.05 mg
EUR 261
Description: His tagged recombinant mouse AHA1 Protein expressed in E. coli for WB, SDS-PAGE, Functional Assay. The biological activity of this protein has not yet been tested.

Mouse AHA1 Protein

SPR-311B 0.1 mg
EUR 377
Description: His tagged recombinant mouse AHA1 Protein expressed in E. coli for WB, SDS-PAGE, Functional Assay. The biological activity of this protein has not yet been tested.

Mouse AHA1 Protein

SPR-311C 2x0.1 mg
EUR 564
Description: His tagged recombinant mouse AHA1 Protein expressed in E. coli for WB, SDS-PAGE, Functional Assay. The biological activity of this protein has not yet been tested.

anti-AHA1

YF-PA17082 50 ul
EUR 363
Description: Mouse polyclonal to AHA1

anti-AHA1

YF-PA17083 50 ug
EUR 363
Description: Mouse polyclonal to AHA1

anti-AHA1

YF-PA17084 100 ul
EUR 403
Description: Rabbit polyclonal to AHA1

anti-AHA1

YF-PA17085 100 ug
EUR 403
Description: Rabbit polyclonal to AHA1

AHA1 antibody

70R-50815 100 ul
EUR 244
Description: Purified Polyclonal AHA1 antibody

Recombinant Yeast IDH1 Protein, Untagged, Yeast-1mg

QP10670-1mg 1mg
EUR 155

Recombinant Yeast IDH1 Protein, Untagged, Yeast-50mg

QP10670-50mg 50mg
EUR 1043

Recombinant Yeast IDH1 Protein, Untagged, Yeast-5mg

QP10670-5mg 5mg
EUR 201

GLC8 Yeast Recombinant Protein

PROTP41818 Regular: 50ug
EUR 317
Description: GLC8 Yeast (Saccharomyces cerevisiae) Recombinant produced in E.coli is a single, glycosylated polypeptide chain containing 265 amino acids (1-229) and having a molecular mass of 30.7 kDa (molecular size on SDS-PAGE will appear higher). ;The GLC8 is fused to a 35 amino acid His Tag at N-Terminus and purified by standard chromatography techniques.

AHA1 Blocking Peptide

20-abx063690
  • EUR 272.00
  • EUR 411.00
  • 1 mg
  • 5 mg

AHA1 Antibody (Biotin)

abx447922-100ul 100 ul
EUR 551

AHA1 Antibody (FITC)

abx447923-100ul 100 ul
EUR 551

AHA1 Antibody (HRP)

abx447924-100ul 100 ul
EUR 537

Human AHA1 Antibody

32922-05111 150 ug
EUR 261

Recombinant Yeast GLRX1 Yeast Protein, His, E.coli-10ug

QP11990-10ug 10ug
EUR 155

Recombinant Yeast GLRX1 Yeast Protein, His, E.coli-1mg

QP11990-1mg 1mg
EUR 1561

Recombinant Yeast GLRX1 Yeast Protein, His, E.coli-50ug

QP11990-50ug 50ug
EUR 201

Recombinant Yeast GLRX2 Yeast Protein, His, E.coli-10ug

QP11991-10ug 10ug
EUR 155

Recombinant Yeast GLRX2 Yeast Protein, His, E.coli-1mg

QP11991-1mg 1mg
EUR 1561

Recombinant Yeast GLRX2 Yeast Protein, His, E.coli-50ug

QP11991-50ug 50ug
EUR 201

AHA1 Activator of HSP90 ATPase-1 Human Recombinant Protein

PROTO95433 Regular: 50ug
EUR 317
Description: AHA1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 320 amino acids (19-337) and having a molecular mass of 36.1 kDa.

Recombinant Saccharomyces Cerevisiae AHA1 Protein (aa 1-350) [His]

VAng-Wyb4128-1mg 1 mg
EUR 4604
Description: Saccharomyces Cerevisiae (strain ATCC 204508 / S288c) Aha1p protein, recombinant protein.

Recombinant Yeast Kex-2 Protein

PROTP13134 250ug
EUR 317
Description: Proteases (also called Proteolytic Enzymes, Peptidases, or Proteinases) are enzymes that hydrolyze the amide bonds within proteins or peptides. Most proteases act in a specific manner, hydrolyzing bonds at or adjacent to specific residues or a specific sequence of residues contained within the substrate protein or peptide. Proteases play an important role in most diseases and biological processes including prenatal and postnatal development, reproduction, signal transduction, the immune response, various autoimmune and degenerative diseases, and cancer. They are also an important research tool, frequently used in the analysis and production of proteins. Kex-2 cleaves at the carboxyl end of the recognition sequences Arg-Arg/X and Lys-Arg/X. Recombinant Yeast Kex-2 is a 60.4 kDa protease consisting of 558 amino acid residues.

Yeast Kex-2 Recombinant Protein

P1279-250
EUR 425

Yeast Kex-2 Recombinant Protein

P1279-50
EUR 175

Yeast Kex-2 Recombinant Protein

40-539-005mg 0.05 mg
EUR 259.25
Description: Proteases (also called Proteolytic Enzymes, Peptidases, or Proteinases) are enzymes that hydrolyze the amide bonds within proteins or peptides. Most proteases act in a specific manner, hydrolyzing bonds at or adjacent to specific residues or a specific sequence of residues contained within the substrate protein or peptide. Proteases play an important role in most diseases and biological processes including prenatal and postnatal development, reproduction, signal transduction, the immune response, various autoimmune and degenerative diseases, and cancer. They are also an important research tool, frequently used in the analysis and production of proteins. Kex-2 cleaves at the carboxyl end of the recognition sequences Arg-Arg/X and Lys-Arg/X. Recombinant Yeast Kex-2 is a 59.9 kDa protease consisting of 554 amino acid residues.

Yeast Kex-2 Recombinant Protein

40-539-025mg 0.25mg
EUR 364.25
Description: Proteases (also called Proteolytic Enzymes, Peptidases, or Proteinases) are enzymes that hydrolyze the amide bonds within proteins or peptides. Most proteases act in a specific manner, hydrolyzing bonds at or adjacent to specific residues or a specific sequence of residues contained within the substrate protein or peptide. Proteases play an important role in most diseases and biological processes including prenatal and postnatal development, reproduction, signal transduction, the immune response, various autoimmune and degenerative diseases, and cancer. They are also an important research tool, frequently used in the analysis and production of proteins. Kex-2 cleaves at the carboxyl end of the recognition sequences Arg-Arg/X and Lys-Arg/X. Recombinant Yeast Kex-2 is a 59.9 kDa protease consisting of 554 amino acid residues.

TM Yeast Pst1 Recombinant Protein

95-151 0.05 mg
EUR 322.25
Description: Protoplast secreted protein 1 (Pst1) is an anchored plasma membrane protein. Pst1 was previously identified as a protein secreted by yeast regenerating protoplasts, which suggests a role in cell wall construction (1). Pst1 is a protein with 444 amino acids and is attached to yeast cell wall via a glycosylphosphatidylinisotol (GPI) anchor (2). Pst1 contains 15 potential N-linked glycosylation sites and is heavily glycosylated. It migrates at around 200 kDa on SDS-PAGE when produced in wild type S. cerevisiae. Our Pst1 protein was expressed in a genetically manipulated triple-mutant (TM) S. cerevisiae stain (Δoch1 Δmnn1 Δmnn4), which results in the production of sole Man8GlcNAc2 carbohydrate structures and Pst1 migration at approximately 100 kDa. When produced in the TM yeast, Pst1 can be recognized by several HIV-1 broadly neutralizing antibodies, including 2G12 and recently identified glycan-specific PGT antibodies (3). Among several heavily N-glycosylated TM yeast glycoproteins, Pst1 shows high affinity for 2G12 and efficiently inhibits gp120 interactions with 2G12 and DC-SIGN, and it also blocks 2G12-mediated neutralization of HIV-1 pseudoviruses (4).

Recombinant Yeast GLC8

7-05266 10µg Ask for price

Recombinant Yeast GLC8

7-05267 50µg Ask for price

Recombinant Yeast GLC8

7-05268 1mg Ask for price

Recombinant Yeast Thioredoxin

7-06895 5µg Ask for price

Recombinant Yeast Thioredoxin

7-06896 20µg Ask for price

Recombinant Yeast Thioredoxin

7-06897 1mg Ask for price

Recombinant (yeast) Hirudin

RP-820 10 ug
EUR 286

Anti-AHA1 Monoclonal Antibody

M05733-1 100ug
EUR 397
Description: Rat Monoclonal AHA1 Antibody. Validated in ELISA, IP, IF, IHC, WB and tested in Human, Mouse, Rat.

Anti-AHA1/AHSA1 Antibody

A05733 100ug/vial
EUR 294

Monoclonal antibody for AHA1

SMC-198D 0.1mg
EUR 332
Description: A monoclonal antibody from clone 4H9-D7 against Rat | Mouse AHA1. The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Aha1, his tagged. The antibody is tested and validated for WB, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This MAb for AHA1 is not conjugated.

Monoclonal antibody for AHA1

SMC-198D-A390 0.1mg
EUR 379
Description: A monoclonal antibody from clone 4H9-D7 against Rat | Mouse AHA1. The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Aha1, his tagged. The antibody is tested and validated for WB, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This MAb for AHA1 is conjugated with ATTO 390.

Monoclonal antibody for AHA1

SMC-198D-A488 0.1mg
EUR 378
Description: A monoclonal antibody from clone 4H9-D7 against Rat | Mouse AHA1. The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Aha1, his tagged. The antibody is tested and validated for WB, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This MAb for AHA1 is conjugated with ATTO 488.

Monoclonal antibody for AHA1

SMC-198D-A565 0.1mg
EUR 378
Description: A monoclonal antibody from clone 4H9-D7 against Rat | Mouse AHA1. The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Aha1, his tagged. The antibody is tested and validated for WB, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This MAb for AHA1 is conjugated with ATTO 565.

Monoclonal antibody for AHA1

SMC-198D-A594 0.1mg
EUR 378
Description: A monoclonal antibody from clone 4H9-D7 against Rat | Mouse AHA1. The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Aha1, his tagged. The antibody is tested and validated for WB, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This MAb for AHA1 is conjugated with ATTO 594.

Monoclonal antibody for AHA1

SMC-198D-A633 0.1mg
EUR 378
Description: A monoclonal antibody from clone 4H9-D7 against Human | Mouse | Rat AHA1. The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Aha1, his tagged. The antibody is tested and validated for WB, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This MAb for AHA1 is conjugated with ATTO 633.

Monoclonal antibody for AHA1

SMC-198D-A655 0.1mg
EUR 378
Description: A monoclonal antibody from clone 4H9-D7 against Human | Mouse | Rat AHA1. The host species for the production of this antibody is Mouse. The antigen used for immunization is Human Aha1, his tagged. The antibody is tested and validated for WB, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This MAb for AHA1 is conjugated with ATTO 655.

Regenerative impact of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) after sequestrectomy of medication-related osteonecrosis of the jaw (MRONJ)

 

 

Aims: Past the unique software permitted by the U.S. Meals and Drug Administration, recombinant human bone morphogenetic protein-2 (rhBMP-2) is used for medication-related osteonecrosis of the jaw (MRONJ) remedy due to its bone transforming enhancement properties. The aim of the research was to analyze the bone formation impact of rhBMP-2/absorbable collagen sponge (ACS) in sufferers with MRONJ.

 

 

Supplies and strategies: On this retrospective cohort research, 26 feminine sufferers recognized with MRONJ and who underwent mandibular sequestrectomy at Ajou College Dental Hospital from 2010 to 2018 had been included. The experimental group was composed of 18 sufferers who acquired rhBMP-2/ACSafter sequestrectomy, whereas the management group was composed of Eight sufferers who didn’t obtain rhBMP-2/ACS after sequestrectomy. A complete dose of 0.5 mg of rhBMP-2 was used within the experimental group at a focus of 0.5 mg/mL.

 

Observe-up panoramic X-rays had been taken instantly after the surgical procedure and greater than 6 months after the surgical procedure. Utilizing these X-rays, a radiographic index of bone defect space was calculated utilizing the modified Ihan Hren technique, which measures radiographic density of the conventional bone and the defect web site.

 

 

Outcomes: This research means that rhBMP-2 contributes to new bone formation. The imply radiographic index instantly after surgical procedure and greater than 6 months after the surgical procedure for the experimental group was 68.4% and 79.8%, respectively. The imply radiographic index instantly after surgical procedure and greater than 6 months after the surgical procedure for the management group was 73.4% and 76.7%, respectively (Wilcoxon signed rank take a look at, P>0.05). The imply radiographic index elevated 11.4% within the experimental group and three.27% within the management group (Mann-Whitney U-test, P <0.05).

 

Conclusion: Based mostly on the outcomes, use of rhBMP-2/ACS on bone defect websites after sequestrectomy might be a profitable technique for remedy of MRONJ sufferers.

 

Key phrases: Bisphosphonate-associated osteonecrosis of the jaw; Osteomyelitis; Osteonecrosis; Recombinant human bone morphogenetic protein-2.

 

 

Utility of the Leishmania infantum 21 kDa recombinant protein for the event of an immunochromatographic take a look at

 

Human Alpha Synuclein A30P/A53T Recombinant double mutant protein

SYN-A3053T-R 50ug
EUR 263

Alpha-Synuclein Recombinant Protein

11-240 0.2 mg
EUR 390.5
Description: Neuronal protein that plays several roles in synaptic activity such as regulation of synaptic vesicle trafficking and subsequent neurotransmitter release. Participates as a monomer in synaptic vesicle exocytosis by enhancing vesicle priming, fusion and dilation of exocytotic fusion pores. Mechanistically, acts by increasing local Ca2+ release from microdomains which is essential for the enhancement of ATP-induced exocytosis. Acts also as a molecular chaperone in its multimeric membrane-bound state, assisting in the folding of synaptic fusion components called SNAREs (Soluble NSF Attachment Protein REceptors) at presynaptic plasma membrane in conjunction with cysteine string protein-alpha/DNAJC5. This chaperone activity is important to sustain normal SNARE-complex assembly during aging. Plays also a role in the regulation of the dopamine neurotransmission by associating with the dopamine transporter (DAT1) and thereby modulating its activity.

alpha-Synuclein Recombinant Protein

92-119 0.05 mg
EUR 311.75
Description: Alpha-Synuclein (SNCA) is a member of the Synuclein family. SNCA is expressed principally in brain but also expressed in low concentrations in all tissues except liver. SNCA interacts with UCHL1, Phospholipase D and histones. SNCA can include beta- and gamma-synuclein. In addition, SNCA is an important regulatory component of vesicular transport in neuronal cells. It has been suggested that SNCA is related to the pathogenesis of Parkinson's Disease and neurodegenerative disorders. Defects in SNCA will lead to Dementia Lewy Body (DLB).

alpha-Synuclein Recombinant Protein

92-261 0.05 mg
EUR 311.75
Description: Alpha-Synuclein (SNCA) is a member of the Synuclein family. SNCA is expressed principally in brain but also expressed in low concentrations in all tissues except liver. SNCA interacts with UCHL1, Phospholipase D and histones. SNCA can include beta- and gamma-synuclein. In addition, SNCA is an important regulatory component of vesicular transport in neuronal cells. It has been suggested that SNCA is related to the pathogenesis of Parkinson's Disease and neurodegenerative disorders. Defects in SNCA will lead to Dementia Lewy Body (DLB).

alpha-synuclein Recombinant Protein

92-520 0.05 mg
EUR 616.25
Description: Alpha-synuclein (Snca) belongs to a family of proteins including a-, b-, and g-synucleins. Alpha-synuclein has been found to be implicated in the pathophysiology of many neurodegenerative diseases, including Parkinson's disease (PD) and Alzheimer's disease. Manyneurodegenerative diseases has shown that alpha-synuclein accumulates in dystrophic neurites and in Lewy bodies. The function of alpha-synuclein is closely correlated with its three-dimensional structure, especially for proteins important in the pathogenesis of neurodegenerative diseases. Alpha-synuclein is a dynamic molecule whose secondary structure depends on the environment. For example, it has an unfolded random coil structure in aqueous solution, forms a-helical structure upon binding to acidic phospholipid vesicles, and forms insoluble fibrils with a high b-sheet content that resemble the filaments found in Lewy bodies. Also, alpha-synuclein was known to associate with 14-3-3 proteins including protein kinase C, BAD, and extracellular regulated kinase, and overexpression of alpha-synuclein could contribute to cell death in neurodegenerative diseases.

alpha-synuclein Recombinant Protein

92-615 0.05 mg
EUR 311.75
Description: Alpha-Synuclein (SNCA) is a member of the Synuclein family. SNCA is expressed principally in brain but also expressed in low concentrations in all tissues except liver. SNCA interacts with UCHL1, Phospholipase D and histones. SNCA can include beta- and gamma-synuclein. In addition, SNCA is an important regulatory component of vesicular transport in neuronal cells. It has been suggested that SNCA is related to the pathogenesis of Parkinson's Disease and neurodegenerative disorders. Defects in SNCA will lead to Dementia Lewy Body (DLB).

Recombinant Human Alpha-Synuclein

7-04429 20µg Ask for price

Recombinant Human Alpha-Synuclein

7-04430 100µg Ask for price

Recombinant Human Alpha-Synuclein

7-04431 1mg Ask for price

Recombinant purified Human Alpha Synuclein mutant protein (1-60 aa)

SYN-160-R 50ug
EUR 263

Recombinant purified Human Alpha Synuclein mutant protein (1-95 aa)

SYN-195-R 50ug
EUR 263

Recombinant purified Human Alpha Synuclein mutant protein (61-140 aa)

SYN-61140-R 50ug
EUR 263

Recombinant Human Beta-Synuclein

RP-848 20 ug
EUR 164

Recombinant Human Gamma-Synuclein

RP-849 20 ug
EUR 164

Recombinant Human SNCA/Alpha-synuclein Protein

RP00610 10 μg
EUR 126

SNCA Alpha Synuclein Human Recombinant Protein

PROTP37840-8 Regular: 100ug
EUR 317
Description: a-Synuclein Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain of 140 amino acids having a molecular mass of 14.4kDa (Real molecular weight on SDS-PAGE will be shift up).  ;The Recombinant Human a-Synuclein is purified by proprietary chromatographic techniques.

Human Alpha Synuclein protein W. blot +ve control

SYN11-C 100 ul
EUR 286

Recombinant Human Alpha-Synuclein A30P

7-04432 20µg Ask for price

Recombinant Human Alpha-Synuclein A30P

7-04433 100µg Ask for price

Recombinant Human Alpha-Synuclein A30P

7-04434 1mg Ask for price

Recombinant Human Alpha-Synuclein A53T

7-04435 20µg Ask for price

Recombinant Human Alpha-Synuclein A53T

7-04436 100µg Ask for price

Recombinant Human Alpha-Synuclein A53T

7-04437 1mg Ask for price

Recombinant Human Alpha-Synuclein NACP112

7-04444 20µg Ask for price

Recombinant Human Alpha-Synuclein NACP112

7-04445 100µg Ask for price

Recombinant Human Alpha-Synuclein NACP112

7-04446 1mg Ask for price

Recombinant Mouse Alpha-Synuclein

7-04456 5µg Ask for price

Recombinant Mouse Alpha-Synuclein

7-04457 20µg Ask for price

Recombinant Mouse Alpha-Synuclein

7-04458 1mg Ask for price

Recombinant Synuclein Alpha (SNCa)

4-RPB222Hu01
  • EUR 512.16
  • EUR 240.00
  • EUR 1645.60
  • EUR 615.20
  • EUR 1130.40
  • EUR 406.00
  • EUR 3964.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Synuclein Alpha expressed in: E.coli

Recombinant Synuclein Alpha (SNCa)

4-RPB222Mu01
  • EUR 512.16
  • EUR 240.00
  • EUR 1645.60
  • EUR 615.20
  • EUR 1130.40
  • EUR 406.00
  • EUR 3964.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Synuclein Alpha expressed in: E.coli

Recombinant Synuclein Alpha (SNCa)

4-RPB222Ra01
  • EUR 519.33
  • EUR 242.00
  • EUR 1672.48
  • EUR 624.16
  • EUR 1148.32
  • EUR 410.00
  • EUR 4031.20
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat Synuclein Alpha expressed in: E.coli

alpha Synuclein protein

30R-1000 100 ug
EUR 300
Description: Purified recombinant Human alpha Synuclein protein

alpha Synuclein protein

30R-1001 100 ug
EUR 300
Description: Purified recombinant Human alpha Synuclein protein

alpha synuclein protein

30R-3032 200 ug
EUR 354
Description: Purified recombinant alpha synuclein protein

Recombinant purified Human Alpha Synuclein mutant protein (Delta NAC/96-140 aa)

SYN-96140-R 50ug
EUR 263

Recombinant purified Human Alpha Synuclein protein (140 aa full length, wild type)

SYN11-R-50 50 ug
EUR 286

Human Synuclein-alpha Control/blocking peptide #1

SYN11-P 100 ug
EUR 164